Clinical Experience with Creatine Phosphate Therapy
Authors:
- Paolo PaulettoPPPaolo Pauletto
- Ettore StrumiaESEttore Strumia
- 1 January 1996
- book chapter
- Published by Elsevier
- p. 185-198
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Hemodynamic effects of creatine phosphate in patients with congestive heart failure: A double‐blind comparison trial versus placeboClinical Cardiology, 1996
- Diastolic function and creatine phosphate: An echocardiographic studyCurrent Therapeutic Research, 1993
- Phosphocreatine: Molecular and cellular aspects of the mechanism of cardioprotective actionCurrent Therapeutic Research, 1993
- Multicenter controlled study of creatine phosphate in the treatment of heart failureCurrent Therapeutic Research, 1992
- Biochemical changes induced in the myocardial cell during cardioplegic arrest supplemented with creatine phosphateJournal of Cardiothoracic and Vascular Anesthesia, 1991
- Reduction of ventricular arrhythmias by phosphocreatine (Neoton) in patients with acute myocardial infarctionAmerican Heart Journal, 1988
- Creatine phosphate and protection against reperfusion-induced arrhythmias in the rat heartEuropean Journal of Pharmacology, 1986
- Creatine Phosphate Suppresses Ventricular Arrhythmias Resulting from Coronary Artery LigationJournal of Cardiovascular Pharmacology, 1982
- The response of isolated cardiac muscle to acute anoxia: protective effect of adenosine triphosphate and creatine phosphateJournal of Pharmacy and Pharmacology, 1974
- Reduction in ventricular arrhythmias following acute coronary artery ligation in the dog after the administration of creatine phosphateNaunyn-Schmiedeberg's Archives of Pharmacology, 1974